Site Search

... led to targeted cancer therapies that can improve patient survival and quality life. Treatment with targeted therapy often requires diagnostic testing to analyze biological samples taken from patients to identify and evaluate cancer biomarkers. Testing patients for specific biomarkers is integral to precision medicine in cancer care, but despite evidence pointing to the clinical benefits associated with biomarker testing, routine clinical use does not always follow, and testing rates lag behind clinical guideline recommendations. As highlighted in a recent ACS CAN survey of cancer patients and survivors, only one-third of respondents reported having biomarker testing. Of those who reported not receiving biomarker testing, more than a quarter said it was because insurance would not cover it or ...

Your Senator helped pass biomarker testing through the Senate! Send them a quick message to say thanks. 0 The Senate Passed Biomarker Testing! ...

... Washington gathered at the Capitol on Monday to ask legislators to support House Bill 1450, which would have expanded insurance coverage of biomarker testing and made sure as many state residents as possible have access to this technology. They were disappointed to learn that the bill did not ... “While we are disappointed by the legislature not moving HB 1450 forward, we are determined to keep advocating for patients to have access to biomarker testing and the treatment that is right for them,” said Matt Helder, Washington Government Relations Director. “Washington is known ...

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Maine residents can benefit from this important testing.   What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of ...